(Q40586601)

21 September 2017

Plasminogen activator inhibitor-1 increases the expression of VEGF in human glioma cells (English)

1 reference

21 September 2017

9

Olav Engebraaten

1 reference

21 September 2017

Geir Olav Hjortland

1

1 reference

21 September 2017

Trine Lillehammer

2

1 reference

21 September 2017

Stig Somme

3

1 reference

21 September 2017

Junbai Wang

4

1 reference

21 September 2017

Thomas Halvorsen

5

1 reference

21 September 2017

Siri Juell

6

1 reference

21 September 2017

Henry Hirschberg

7

1 reference

21 September 2017

Øystein Fodstad

8

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

Experimental Cell Research

21 September 2017

1 reference

21 September 2017

294

1 reference

21 September 2017

1

1 reference

21 September 2017

130-139

1 reference

Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

Vascular-specific growth factors and blood vessel formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

Human adenovirus vectors for gene transfer into mammalian cells

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Significance analysis of microarrays applied to the ionizing radiation response

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

Isolation, characterization and chromosomal localization of the human GADD153 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

PAI-1 and EGFR expression in adult glioma tumors: toward a molecular prognostic classification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

Regulation of angiogenesis by hypoxia: role of the HIF system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

The biology of VEGF and its receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

PAI-1 inhibits urokinase-induced chemotaxis by internalizing the urokinase receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

Modulation of glioma cell invasion and motility by adenoviral gene transfer of PAI-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.10.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEXCR.2003.10.013

1 reference

21 September 2017

1 reference